PC
Pharmos Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Johnston Robert F, was filed 30 Mar 2011.
Pharmos Corp: what insiders have been doing
Pharmos Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Pharmos Corp. The previous disclosure was published on 30 March 2011.
Over the whole record (from 2006), the tally stands at 25 purchases and 2 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
47
Thresholds
n/a
Buy Volume
€589,667
25 ops. · all time
Sell Volume
€30,652
2 ops. · all time
Last declaration on 30 March 2011
Declarations47 total
- 3,628 shares@ US$0.09common stockSEC:0001422645-11-000009:0Canonical exit: 26 Jun 2011 (T+90)
- 8,999 shares@ US$0.09common stockSEC:0001422645-11-000008:0Canonical exit: 21 Jun 2011 (T+90)
- 57,015 shares@ US$0.09common stockSEC:0001422645-11-000006:0Canonical exit: 19 Jun 2011 (T+90)
- 81,708 shares@ US$0.09common stockSEC:0001422645-11-000007:0Canonical exit: 20 Jun 2011 (T+90)
- 42,910 shares@ US$0.09common stockSEC:0001422645-11-000005:0Canonical exit: 6 Jun 2011 (T+90)
- 4,590 shares@ US$0.085common stockSEC:0001422645-11-000004:0Canonical exit: 1 Jun 2011 (T+90)
- 52,500 shares@ US$0.0895common stockSEC:0001422645-11-000003:0Canonical exit: 30 May 2011 (T+90)
- 54,000 shares@ US$0.10common stockSEC:0001422645-11-000001:0Canonical exit: 29 Mar 2011 (T+90)
- 20,000 shares@ US$0.0999common stockSEC:0001422645-11-000001:1Canonical exit: 30 Mar 2011 (T+90)
- 81,190 shares@ US$0.10common stockSEC:0001422645-10-000005:0Canonical exit: 23 Mar 2011 (T+90)
- 6,840 shares@ US$0.10common stockSEC:0001422645-10-000004:0Canonical exit: 20 Mar 2011 (T+90)
- 7,000 shares@ US$0.10common stockSEC:0001422645-10-000004:1Canonical exit: 21 Mar 2011 (T+90)
- 4,970 shares@ US$0.10common stockSEC:0001422645-10-000004:2Canonical exit: 22 Mar 2011 (T+90)
- 34,000 shares@ US$0.074common stockSEC:0001422645-10-000003:0Canonical exit: 8 Nov 2010 (T+90)
- 23,000 shares@ US$0.075common stockSEC:0001422645-10-000003:1Canonical exit: 8 Nov 2010 (T+90)
- 350,000 shares@ US$0.0642common stockSEC:0001422645-10-000001:0
- 244,382 shares@ US$0.0597common stockSEC:0001422645-10-000001:1
- 371,129 shares@ US$0.054Common StockSEC:0001209191-10-016854:0
- 66,803 shares@ US$0.054Common StockSEC:0001209191-10-016858:0
- 296,904 shares@ US$0.054Common StockSEC:0001209191-10-016858:1
- 7,422 shares@ US$0.054Common StockSEC:0001209191-10-016858:2
- 543,427 shares@ US$0.054Common StockSEC:0001181431-09-024476:0
- 370,432 shares@ US$0.054Common StockSEC:0001239241-09-000007:0
- 543,427 shares@ US$0.054Common StockSEC:0001181431-09-024475:0
- 99,660 shares@ US$0.054common stockSEC:0001422645-09-000004:0
25 of 47 declarations
About Pharmos Corp
Pharmos Corp is a company listed on the XNAS market. It specializes in the development of innovative therapeutic solutions.
